Authors:
Abood, ME
Rizvi, G
Sallapudi, N
McAllister, SD
Citation: Me. Abood et al., Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity, NEUROSCI L, 309(3), 2001, pp. 197-201
Authors:
Kinard, TA
Goforth, PB
Tao, Q
Abood, ME
Teague, J
Satin, LS
Citation: Ta. Kinard et al., Chloride channels regulate HIT cell volume but cannot fully account for swelling-induced insulin secretion, DIABETES, 50(5), 2001, pp. 992-1003
Authors:
Griffin, G
Williams, S
Aung, MM
Razdan, RK
Martin, BR
Abood, ME
Citation: G. Griffin et al., Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues, BR J PHARM, 132(2), 2001, pp. 525-535
Authors:
Aung, MM
Griffin, G
Huffman, JW
Wu, MJ
Keel, C
Yang, B
Showalter, VM
Abood, ME
Martin, BR
Citation: Mm. Aung et al., Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1and CB2 receptor binding, DRUG AL DEP, 60(2), 2000, pp. 133-140
Authors:
Huffman, JW
Liddle, J
Yu, S
Aung, MM
Abood, ME
Wiley, JL
Martin, BR
Citation: Jw. Huffman et al., 3-(1 ',1 '-dimethylbutyl)-1-deoxy-Delta(8)-THC and related compounds: Synthesis of selective ligands for the CB2 receptor, BIO MED CH, 7(12), 1999, pp. 2905-2914
Authors:
Tao, Q
Mcallister, SD
Andreassi, J
Nowell, KW
Cabral, GA
Hurst, DP
Bachtel, K
Ekman, MC
Reggio, PH
Abood, ME
Citation: Q. Tao et al., Role of a conserved lysine residue in the peripheral cannabinoid receptor (CB2): Evidence for subtype specificity, MOLEC PHARM, 55(3), 1999, pp. 605-613
Authors:
McAllister, SD
Griffin, G
Satin, LS
Abood, ME
Citation: Sd. Mcallister et al., Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a Xenopus oocyte expression system, J PHARM EXP, 291(2), 1999, pp. 618-626
Authors:
Ng, EW
Aung, MM
Abood, ME
Martin, BR
Razdan, RK
Citation: Ew. Ng et al., Unique analogues of anandamide: Arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas, J MED CHEM, 42(11), 1999, pp. 1975-1981
Authors:
Griffin, G
Wray, EJ
Tao, Q
McAllister, SD
Rorrer, WK
Aung, MM
Martin, BR
Abood, ME
Citation: G. Griffin et al., Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528:further evidence for cannabinoid CB2 receptor absence in the rat central nervous system, EUR J PHARM, 377(1), 1999, pp. 117-125
Citation: Md. Aceto et al., Stereoselective mu- and delta-opioid receptor-related antinociception and binding with (+)-thebaine, EUR J PHARM, 365(2-3), 1999, pp. 143-147
Citation: G. Griffin et al., Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum, BR J PHARM, 128(3), 1999, pp. 684-688
Authors:
Griffin, G
Wray, EJ
Rorrer, WK
Crocker, PJ
Ryan, WJ
Saha, B
Razdan, RK
Martin, BR
Abood, ME
Citation: G. Griffin et al., An investigation into the structural determinants of cannabinoid receptor ligand efficacy, BR J PHARM, 126(7), 1999, pp. 1575-1584
Authors:
Reggio, PH
Basu-Dutt, S
Barnett-Norris, J
Castro, MT
Hurst, DP
Seltzman, HH
Roche, MJ
Gilliam, AF
Thomas, BF
Stevenson, LA
Pertwee, RG
Abood, ME
Citation: Ph. Reggio et al., The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 andCB2 receptors: Insights gained from (E)- and (Z)-naphthylidene indenes, J MED CHEM, 41(26), 1998, pp. 5177-5187